Insulin resistance due to a reduction of the post-receptor insulin signaling pathway and the reduction of insulin secretion through a direct effect on the pancreatic beta cells, as well as the reduction of glucose transport and intracellular use in peripheral tissues, are the primary causes of the adverse effects of mTOR (mammalian target of rapamycin) inhibitors on glucose metabolism [40]. The gene discussed is INS; the disease is Insulin resistance.